Type your tag names separated by a space and hit enter

    Sofosbuvir + Ledipasvir

    Janessa M. Smith, PharmD, BCPS
    Sofosbuvir + Ledipasvir is a topic covered in the Johns Hopkins ABX Guide.

    To view the entire topic, please or purchase a subscription.

    Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

    Johns Hopkins Guides

    -- The first section of this topic is shown below --

    INDICATIONS

    FDA

    • Treatment of chronic hepatitis C virus (HCV) genotype 1, 4, 5 or 6 infection.
      • Indicated for treatment of HCV infection in treatment-experienced patients without cirrhosis and with compensated cirrhosis (Child-Pugh A) or decompensated cirrhosis (Child-Pugh B or C)
      • Treatment-naïve patients with compensated cirrhosis (Child-Pugh A) or decompensated cirrhosis (Child-Pugh B or C), and liver transplant recipients.

    -- To view the remaining sections of this topic, please or purchase a subscription --

    Last updated: July 31, 2016

    Citation

    * When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
    TY - ELEC T1 - Sofosbuvir + Ledipasvir ID - 540671 A1 - Smith,Janessa,PharmD, BCPS Y1 - 2016/07/31/ BT - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540671/all/Sofosbuvir_+_Ledipasvir PB - The Johns Hopkins University DB - Johns Hopkins Guide DP - Unbound Medicine ER -